tiprankstipranks
Immucell Corp. (ICCC)
NASDAQ:ICCC

Immucell (ICCC) Income Statement

69 Followers

Immucell Income Statement

Last quarter (Q4 2023), Immucell's total revenue was $5.10M, an increase of 30.30% from the same quarter last year. In Q4, Immucell's net income was $-1.14M. See Immucell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 17.47M$ 17.47M$ 18.57M$ 19.24M$ 15.34M$ 13.72M
Cost of Revenue
$ 7.31M$ 13.60M$ 10.92M$ 10.59M$ 8.48M$ 6.98M
Gross Profit
$ 3.87M$ 3.87M$ 7.65M$ 8.66M$ 6.86M$ 6.74M
Operating Expense
$ 4.50M$ 9.62M$ 9.95M$ 8.40M$ 8.24M$ 7.69M
Operating Income
$ 2.21M$ -5.75M$ -2.30M$ 257.38K$ -1.38M$ -953.91K
Net Non Operating Interest Income Expense
$ -199.06K$ -379.03K$ -195.44K$ -295.55K$ -385.25K$ -311.04K
Other Income Expense
$ -3.54M$ 21.89K$ 187.19K$ 326.51K$ 733.35K$ -2.47K
Pretax Income
$ -5.77M$ -5.77M$ -2.49M$ -69.13K$ -1.03M$ -1.27M
Tax Provision
$ 1.58K$ 4.63K$ 7.67K$ 9.16K$ -10.14K$ 28.17K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 5.75M$ -5.77M$ -2.49M$ -78.29K$ -1.02M$ -1.30M
Basic EPS
$ -0.75$ -0.75$ -0.32$ -0.01$ -0.14$ -0.19
Diluted EPS
$ -0.75$ -0.75$ -0.32$ -0.01$ -0.14$ -0.19
Basic Average Shares
$ 30.99M$ 7.75M$ 7.75M$ 7.59M$ 7.21M$ 6.82M
Diluted Average Shares
$ 30.99M$ 7.75M$ 7.75M$ 7.59M$ 7.21M$ 6.82M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 11.81M$ 23.22M$ 20.87M$ 18.99M$ 16.72M$ 14.68M
Net Income From Continuing And Discontinued Operation
$ -5.77M$ -5.77M$ -2.49M$ -78.29K$ -1.02M$ -1.30M
Normalized Income
$ -3.14M$ -5.02M$ -2.09M-$ -1.91M$ -1.29M
Interest Expense
----$ 412.69K$ 431.79K
EBIT
$ -5.46M$ -5.29M$ -2.14M$ 245.23K$ -619.57K$ -835.63K
EBITDA
$ -2.72M$ -2.55M$ 349.99K$ 2.71M$ 1.73M$ 1.43M
Currency in USD

Immucell Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis